Rasopathies Research Program
About the Rasopathies Research Program
Under the direction of听, the Rasopathies Research program at 糖心Vlog Children鈥檚 Hospital, Delaware investigates Costello syndrome and a variety of genetic mutations referred to as rasopathies.
Research Interests
Costello syndrome, a rare genetic condition resulting from germline mutations in the proto-oncogene HRAS is a multi-organ system disorder entailing a predisposition to malignant tumors. Dr. Gripp has a long-standing interest in the clinical manifestations of Costello syndrome and genotype-phentoype correlation.
Rasopathies:听Genetic conditions resulting from mutations in genes encoding proteins of the Ras/MAPK signaling pathway are collectively referred to as rasopathies. These include the relatively common neurofibromatosis type 1 and Noonan syndrome and the less common cardio-facio-cutaneous and Costello syndrome, amongst others.
Lab Head
Director, Rasopathies Program
Chief, Division of Medical Genetics, 糖心Vlog Children鈥檚 Hospital, Delaware; and Professor of Pediatrics, Thomas Jefferson University
Current Research Group
- 听and her lab
- Beth Denenberg, LGC
- Angela Lin, MD
- Marni Axelrad, PhD
听
Our Location
糖心Vlog Children鈥檚 Hospital, Delaware
1600 Rockland Road
Wilmington, DE 19803
Phone:听(302) 651-5916
Fax:听(302) 651-5033
karen.gripp@nemours.org
Research Interests & Projects
The ongoing research project 鈥淐ostello Syndrome: Clinical and Molecular Investigations鈥 examines specific clinical areas, such as brain abnormalities, cancer predisposition and skeletal abnormalities, in Costello syndrome and related disorders. It aims to establish genotype-phenotype correlations and to assess the outcome of screening and treatment strategies.
This project is collaborative, including specialists of focus areas, such as听听from endocrinology,听听from orthopedics, and collaborators in other institutions, such as Dr. Angela Lin from Harvard Partners, and Dr. Marni Axelrad from Texas Children鈥檚 Hospital.听 Laboratory studies are performed by听, the director of the biomolecular core laboratory, who is a long-standing co-investigator in this research. Additional collaborative efforts include participation in the research project led by Dr. Anders Kolb on tumor treatment in rasopathies.